Paclitaxel Inj Carton (Image 01)
Paclitaxel Injection
Product Images NDC 68001-705
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 68001-705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Paclitaxel-1figure (Paclitaxel 1figure)
This text provides survival analysis data, including the number of participants at risk over the years and the proportion surviving at different time points. Additionally, it shows the number of events that occurred and the hazard ratio with a 95% confidence interval. The data is organized by time points (1, 2, 3, 4 years) for a specific study or analysis.*
Paclitaxel-2figure (Paclitaxel 2figure)
This text seems to describe survival analysis results, indicating the proportion surviving over a certain period. It includes information such as the number of events, hazard ratio, and the number at risk over different time points. The hazard ratio with its corresponding 95% confidence interval is shown as 0.4 (0.50-0.81), suggesting a potential impact on survival. The data may pertain to a specific study or clinical trial tracking survival outcomes over time.*
Paclitaxel Inj Label (Paclitaxel 30mg Vial Label)
This is a description of Paclitaxel Injection, a semisynthetic cytotoxic agent used for intravenous infusion. It contains 300 mg of paclitaxel in 50 mL, with a concentration of 6 mg/mL. The formulation includes Polyoxyl 35 Castor Oil, Dehydrated Alcohol, and Citric Acid. It is recommended to wear gloves when handling the vial and store it between 20°C to 25°C, protected from light. The product is manufactured by Alembic Pharmaceuticals Limited in India for BluePoint Laboratories, a product of Taiwan. The usual dosage is mentioned in the insert.*
Paclitaxel-3figure (Paclitaxel 3figure)
This document appears to show statistics related to disease-free proportion over a span of four years. The data includes the number of events (disease occurrences), hazard ratio (HR) with confidence interval (95% CI), and the number at risk in the AC+T and AC groups over the years. The information presented seems to be part of a study or report analyzing disease-free survival rates.*
Paclitaxel-4figure (Paclitaxel 4figure)
The output appears to show statistical data related to survival rates in a study or clinical trial. It provides information on the proportion surviving over time, with details such as the number of events, hazard ratio (HR), confidence interval, and the number at risk for each group being compared. The data seems to be organized in a table format, possibly showing survival rates for different treatment groups over various time intervals. This information could be helpful for analyzing the effectiveness of a specific treatment or intervention in improving survival outcomes.*
Paclitaxel-5figure (Paclitaxel 5figure)
This description provides data on disease-free proportion, number of events, hazard ratio, and the number of subjects at risk for different treatment groups over time. It appears to be related to a study or clinical trial evaluating the effectiveness of different treatments on disease-free outcomes.*
Paclitaxel-6figure (Paclitaxel 6figure)
This text provides statistical information about a study related to a specific medical treatment or intervention. It includes data on the proportion of individuals remaining disease-free over a period of time (measured in years), as well as details such as hazard ratio (HR) with confidence intervals. The study compares the effectiveness of two types of treatments indicated as AC+T and AC. The number of events, participants at risk, and outcomes over a specified time frame are also presented.*
Paclitaxel-7figure (Paclitaxel 7figure)
This is a statistical report showing the proportion of individuals free from disease over a period of time. The data includes the number of subjects, number of disease events, hazard ratio (HR) with confidence intervals, and the number at risk for different treatment groups represented as AC+T and AC.*
Paclitaxel-8figure (Paclitaxel 8figure)
Proportion of disease-free individuals after 4 years with AC+T treatment compared to AC treatment alone. Number of events, hazard ratio, and confidence interval are provided for comparison. The table also includes the number at risk for each treatment group at different time points.*
Paclitaxel-str (Paclitaxel Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
